| Results summary | View all lists in L2L MDB | View all genes in G03AC.profile.ud50 |
|
Reduced expression in XPC-defective fibroblasts, compared to normal fibroblasts, following treatment with cisplatin enrichment: 3.90-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 214934_AT | ATP9B | T | ATPase, Class II, type 9B | ||||||||||
| 203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
| 201961_S_AT | RNF41 | P | ring finger protein 41 | ||||||||||
| 202437_S_AT | CYP1B1 | E | cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||||
| 206115_AT | EGR3 | D | R | C | early growth response 3 | ||||||||
| 202436_S_AT | CYP1B1 | E | cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||||